What is Arbiter?
Arbiter is developing a sophisticated care orchestration platform designed to bridge the gaps between patients, payers, and providers. At its core, the company utilizes a Record-Action-Alignment model, which integrates disparate clinical, financial, and policy data into a singular, unified patient record. This comprehensive approach enables the automation and synchronization of care actions, effectively addressing care gaps. The platform's initial application is centered on real-time site-of-care optimization, intelligently matching patients with the most suitable providers based on critical factors such as cost, quality, and availability. This strategic focus aims to streamline healthcare delivery and improve patient outcomes.
How much funding has Arbiter raised?
Arbiter has raised a total of $52M across 1 funding round:
Other Financing Round
$52M
Other Financing Round (2025): $52M with participation from MFO Ventures, WindRose Health Investors, and TriEdge Investments
Key Investors in Arbiter
MFO Ventures
MFO Ventures is a family office founded in 2022, specializing in managing family assets and investing in the healthcare sector. They focus on small- to medium-sized companies with high growth potential, particularly in healthcare services and technology, leveraging industry expertise and a strong network.
WindRose Health Investors
WindRose Health Investors, established in 2000 and based in New York City, is an equity investment firm concentrating on the services sectors within the healthcare industry.
TriEdge Investments
TriEdge Investments operates within the Venture Capital & Private Equity industry, headquartered in New York City. The firm is known for its investments in companies within this sector, contributing to the growth of innovative businesses.
What's next for Arbiter?
With the recent major strategic investment, Arbiter is poised for accelerated growth and platform expansion. The enterprise-level funding suggests a transition towards scaling operations, enhancing its AI capabilities, and potentially broadening its market reach. This capital will likely be directed towards further developing its care orchestration technology, solidifying partnerships within the healthcare ecosystem, and driving adoption of its site-of-care optimization solutions. The company's trajectory indicates a strong focus on leveraging AI to create a more efficient and patient-centric healthcare system.
See full Arbiter company page
